| 000 | 02055cam a2200217 4500 | ||
|---|---|---|---|
| 001 | 9780128036327 | ||
| 008 | 220107t2016 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9780128036327 | ||
| 020 | _a9780128036044 | ||
| 041 | _aeng | ||
| 100 | _aGerli, Roberto | ||
| 245 | 0 | _aSjogren's syndrome: novel insights in pathogenic, clinical and therapeutic aspects | |
| 260 |
_aLondon : _bAcademic Press, _c2016 |
||
| 300 | _a1 online resource (xviii, 317 pages):illustrations (chiefly color) | ||
| 505 | _aIntroduction : history of SjoÌgren's syndrome -- Clinical features -- Management of SjoÌgren's syndrome -- Classification criteria for SjoÌgren's syndrome -- Imaging procedures useful for the diagnosis of SjoÌgren's syndrome : abnormalities of the major salivary glands -- SjoÌgren's syndrome--associated lymphoma -- Spontaneous and inducible animal models of SjoÌgren's syndrome -- Genetics, genomics, gene expression profiling, and epigenetics in SjoÌgren's syndrome -- Autoantigens and autoantibodies in the pathogenesis of SjoÌgren's syndrome -- SjoÌgren's syndrome and environmental factors -- Histology of SjoÌgren's syndrome -- Glandular epithelium : innocent bystander or leading actor? -- T cells in the pathogenesis of SjoÌgren's syndrome : more than just Th1 and Th2 -- B lymphocytes in primary SjoÌgren's syndrome -- Cytokines, chemokines, and the innate immune system in SjoÌgren's syndrome -- Autoantibodies and autoantigens in SjoÌgren's syndrome -- Outcome measures in SjoÌgren's syndrome and perspectives in clinical trial design -- Novel therapeutic strategies in SjoÌgren's syndrome : b-cell targeting -- Novel therapeutic strategies in SjoÌgren's syndrome : t-cell targeting -- New biological avenues for SjoÌgren's syndrome." | ||
| 690 | _aSjogren's syndrome. | ||
| 700 | _aBartoloni, Elena | ||
| 700 | _aAlunno, Alessia | ||
| 856 | _uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C2014003362X | ||
| 999 |
_c57304 _d57304 |
||